SNGX
SNGX
NASDAQ · Biotechnology

Soligenix Inc

$1.13
+0.09 (+8.65%)
As of Feb 8, 2:28 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.91M 2.02M 1.51M
Net Income 293.8K 234.8K 245.0K
EPS
Profit Margin 15.4% 11.6% 16.3%
Rev Growth +14.6% +14.4% +1.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 3.74M 3.18M 3.12M
Total Equity 8.22M 9.01M 7.78M
D/E Ratio 0.46 0.35 0.40
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 387.2K 368.8K 310.9K
Free Cash Flow 223.2K 168.2K 121.5K